27 results
Histologic Features and Prevalence of Nonalcoholic Steatohepatitis (NASH). NASH is a potentially progressive type of nonalcoholic
Steatohepatitis (NASH ... NASH is a potentially ... liver disease (NAFLD ... specimens: ballooned hepatocytes ... #NAFLD #NonAlcoholicSteatoHepatitis
NAFLD / NASH Progression Timeline
Healthy Liver → NAFLD/NASH → 0.25-3.2%/year → Cirrhotic NASH → 0.3-2.6%/year →
NAFLD / NASH Progression ... Healthy Liver → NAFLD ... /NASH → 0.25-3.2% ... /year → HCC • NAFLD ... Polymorphisms, Age #NAFLD
Pathogenesis of Nonalcoholic Steatohepatitis. Various factors, including inflammation, hyperinsulinemia or insulin resistance, and altered lipid homeostasis,
develop in fatty hepatocytes ... Pathophysiology #GI #IM #NASH ... #NAFLD #NonAlcoholicSteatoHepatitis
NAFLD Activity Score (NAS)
0–3 for steatosis
0–3 for inflammation
0–2 for ballooning hepatocytes
NAS ≥5 is classified as definitive
NAFLD Activity Score ... (NAS) 0–3 for steatosis ... for ballooning hepatocytes ... as definitive NASH ... .2020.603926 #NAFLD
Assessment of Nonalcoholic Steatohepatitis (NASH) Severity in Patients With Nonalcoholic Fatty
#Diagnosis #Pathology #NAFLD #NASH #Fibrosis #Staging
Steatohepatitis (NASH ... Diagnosis #Pathology #NAFLD ... #NASH #Fibrosis
NASH/NAFLD - Liver Biopsy Indications Algorithm

#NASH #NAFLD #Liver #Biopsy #Indications #Algorithm #diagnosis #hepatology
NASH/NAFLD - Liver ... Algorithm #NASH ... #NAFLD #Liver #
NAFLD Diagnosis Algorithm
Two-step diagnostic strategy for NAFLD
1st step: 
  - Clinical biomarkers, scoring systems- FIB4,
NAFLD Diagnosis ... diagnostic strategy for NAFLD ... systems- FIB4, NAFLD ... Liver #Disease #NAFLD ... Algorithm #hepatology #NASH
Filariform larvae of Strongyloides strongylodiasis on sputum microscopy
BMT patient with abd pain and rash. Treated with
with abd pain and rash ... Video of sputum
Diagnostic flow-chart to assess and monitor disease severity in the presence of suspected NAFLD and metabolic
presence of suspected NAFLD ... #Diagnosis #NASH ... #NAFLD #Nonalcoholic
ANTI-MDA5 DERMATOMYOSITIS

Cutaneous manifestations:
• Periorbital heliotrope (blue-purple) rash with edema
• Erythematous rash on the face, or the
(blue-purple) rash ... • Erythematous rash ... steatosis and hepatocyte